The vaccine industry and its government and scientific partners routinely block meaningful science and fabricate misleading studies about vaccines. They could not do so, however, without having enticed medical journals into a mutually beneficial bargain. Pharmaceutical companies supply journals with needed income, and in return, journals play a key role in suppressing studies that raise critical questions about vaccine risks—which would endanger profits.

Journals are willing to accept even the most highly misleading advertisements. The FDA has flagged numerous instances of advertising violations, including ads that overstated a drug's effectiveness or minimized its risks.

An exclusive and dependent relationship

Advertising is one of the most obviously beneficial ways that medical journals' "exclusive and dependent relationship" with the pharmaceutical industry plays out. According to a 2006 analysis in PLOS Medicine, drugs and medical devices are the only products for which medical journals accept advertisements. Studies show that journal advertising generates "the highest return on investment of all promotional strategies employed by pharmaceutical companies."